Endologix Inc. Reports 24% and 22% Revenue Growth for the Full Year and Fourth Quarter 2011

IRVINE, Calif., Feb. 22, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative medical devices for the treatment of aortic disorders, today announced financial results for the three and twelve months ended December 31, 2011.